Dr. Martha Boeckenfeld Shares VetiGel Creation Experiment: How A 17-Year-Old Mixed Algae in a Small Hidden Lab
Dr. Martha Boeckenfeld, CEO and Founder of the Marthaverse, posted on LinkedIn:
“A 17-year-old mixed algae in a small lab hidden on his grandfather’s Hudson Valley vineyard.

It grabbed wet tissue and wouldn’t let go.
That experiment turned into VetiGel: a plant-based gel that seals wounds and helps blood clot.
Trauma care’s hard problem:
Severe bleeding is the leading cause of preventable trauma death.
A major arterial bleed can kill in 3–5 minutes.
Most products need firm pressure, the right wound shape, and time.
Deep, jagged wounds are tough to pack.
What Joe built:
- A gel that seals fast and triggers clotting
- No manual pressure
- Stops bleeding in under 20 seconds
Works on skin and organs
The proof: In veterinary surgery on 16 dogs, VetiGel cut blood loss from 78 mL to 6.7 mL. Time to hemostasis dropped from 25 minutes to under 2.
Cresilon later created TraumaGel for humans. It’s FDA cleared.
It made Time’s “Best Inventions of 2025.”
The Department of Defense signed on.
Picture an earthquake. A mother pinned under rubble, bleeding from a deep wound. No ambulance for 40 minutes. A responder applies gel. The bleeding stops.
She’s still alive when rescue arrives.
We spent decades accepting some bleeds are too fast and too deep to stop in time. A kid in a vineyard lab didn’t accept that.
Follow me, Dr. Martha Boeckenfeld, for stories where curiosity changes medicine.
Share if you think big medical advances can start everywhere. We just need imagination!
This is my find for YOU on the the last Day of 2025 to show, how human imagination is saving lives!”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Apr 8, 2026, 07:32Giulia Simini: Acquired von Willebrand Syndrome and Coagulation Abnormalities in MPN-Associated Thrombocytosis
-
Apr 8, 2026, 07:14Julian Kyoung-Ryul Chun: Join the Discussion at EHRA 2026
-
Apr 8, 2026, 06:41Stephanie Diez de Sollano: Why Ehlers-Danlos Syndrome Deserves More Attention
-
Apr 7, 2026, 19:17Anand Padmanabhan: Persistence and Pathogenicity of Platelet Factor 4 Antibodies in VITT
-
Apr 7, 2026, 19:07Clara Meijs: Great Time Presenting Our Endometriosis Project at the AHA EPI Lifestyle Conference
-
Apr 7, 2026, 18:18Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions
-
Apr 7, 2026, 17:44Augustina Isioma Ikusemoro: Quality Indicators for Red Blood Cells in Transfusion Medicine
-
Apr 7, 2026, 17:35Nikola Grubor: In Situ Pulmonary Arterial Thrombosis Mimicking CTEPH in Eisenmenger
-
Apr 7, 2026, 17:34Pooja Choradia: vWF Breakdown in Aortic Stenosis – Anaemia and Pulmonary Relevance